ω‐3 Fatty Acids Reduce Chemotherapy‐Induced Hematological Toxicity by Bone Marrow Stimulation in Mice |
| |
Authors: | Kohei Murakami MD Hiroshi Miyata MD PhD Yasuhiro Miyazaki MD PhD Tomoki Makino MD PhD Tsuyoshi Takahashi MD PhD Yukinori Kurokawa MD PhD Makoto Yamasaki MD PhD Kiyokazu Nakajima MD PhD Shuji Takiguchi MD PhD Masaki Mori MD PhD Yuichiro Doki MD PhD |
| |
Institution: | Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan |
| |
Abstract: | Background: ω‐3 Fatty acids exert several benefits during chemotherapy, such as preventing intestinal mucosal damage and improving response to chemotherapy. However, little is known about the effect of ω‐3 fatty acids on chemotherapy‐induced hematological toxicities. Methods: Mice that had consumed either an ω‐3–rich or an ω–3‐poor diet for 2 weeks were intraperitoneally administered cisplatin. The resultant changes in blood cell count, bone marrow cell count, and cytokine levels in bone marrow supernatant were analyzed. The effect of ω‐3 fatty acids on human peripheral blood mononuclear cells (PBMCs) exposed to cisplatin was also examined. Results: Although peripheral blood cell counts decreased after cisplatin treatment in both groups of mice, the decrease in white blood cell count was significantly lower in mice that consumed the ω‐3–rich diet. The decrease in bone marrow cells after cisplatin treatment was also reduced in mice that consumed the ω‐3–rich diet. Levels of stem cell factor (SCF) and fibroblast growth factor 1 (FGF‐1) were significantly higher in bone marrow supernatants from mice that consumed the ω‐3–rich diet. The rate of apoptosis in PBMCs (after exposure to cisplatin) cultured in medium containing ω‐3 fatty acids was significantly lower than in PBMCs cultured in control medium. Conclusion: ω‐3–Rich diets reduced chemotherapy‐induced leukopenia in mice. This may be the result of increased numbers of bone marrow cells due to higher levels of SCF and FGF‐1 in the bone marrow. |
| |
Keywords: | bone marrow chemotherapy hematological toxicity leukopenia ω ‐3 fatty acids |
|